WST (West Pharmaceutical Services) Institutional Ownership: 114.23% (As of Jul. 07, 2026)


WST West Pharmaceutical Services Inc WST
95 GF Score
Price $357.64
GF Value $362.14
Valuation Fairly Valued
! 9 Warning Signs
View Full Analysis

What is West Pharmaceutical Services Institutional Ownership?

West Pharmaceutical Services WST -2.21% 95 Institutional Ownership is 114.23% as of Jul. 07, 2026. GuruFocus rates WST with a GF Score™ of 95/100 and a GF Value™ of $362.14 (Fairly Valued). The stock has 9 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, West Pharmaceutical Services's institutional ownership is 114.23%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, West Pharmaceutical Services's Insider Ownership is 3.53%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, West Pharmaceutical Services's Float Percentage Of Total Shares Outstanding is 85.64%.

West Pharmaceutical Services Institutional Ownership Historical Data

* Premium members only.

The historical data trend for West Pharmaceutical Services's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

West Pharmaceutical Services Institutional Ownership Chart

West Pharmaceutical Services Historical Data

The historical data trend for West Pharmaceutical Services can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 66.41 66.51 66.61 65.47 64.50 63.47 67.34 68.31 68.74 68.47
WST
95GF Score
West Pharmaceutical Services Inc WST
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

West Pharmaceutical Services Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 114.23% mean?
West Pharmaceutical Services (WST) has a Institutional Ownership of 114.23% as of Jul. 07, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on West Pharmaceutical Services and its competitors.
Is West Pharmaceutical Services' Institutional Ownership too high?
West Pharmaceutical Services' current Institutional Ownership is 114.23%. Overall, West Pharmaceutical Services has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does West Pharmaceutical Services' Institutional Ownership compare to RMD and MDLN?
West Pharmaceutical Services' Institutional Ownership of 114.23% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Devices & Instruments company?
A good Institutional Ownership depends on the Medical Devices & Instruments industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on West Pharmaceutical Services and its competitors. West Pharmaceutical Services's current Institutional Ownership is 114.23%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is West Pharmaceutical Services stock overvalued right now?
Based on GuruFocus' analysis, West Pharmaceutical Services (WST) is currently considered Fairly Valued. The stock's GF Value™ is $362.14, compared to a current price of $357.64 — trading 1.2% below its estimated fair value. The current Institutional Ownership is 114.23%. West Pharmaceutical Services' overall GF Score™ is 95/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For West Pharmaceutical Services (WST), the current Institutional Ownership is 114.23% as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is West Pharmaceutical Services (WST) Overvalued in 2026?

Based on GuruFocus' analysis, West Pharmaceutical Services stock appears to be undervalued. The current stock price of $357.64 is trading 1.2% below its estimated GF Value™ of $362.14. GuruFocus considers West Pharmaceutical Services to be Fairly Valued.

Key valuation signals for WST:

  • Institutional Ownership: 114.23%
  • GF Value™: $362.14 vs. price of $357.64 (1.2% below fair value)
  • GF Score™: 95/100 with 9 warning signs

No single metric tells the full story. See the WST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

West Pharmaceutical Services Business Description

Address 530 Herman O. West Drive, Exton, PA, USA, 19341-1147
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
95GF Score

Get the complete analysis for WST

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$357.64
Price
$362.14
GF Value